CONCERT PHARMACEUTICALS INC. Trademark Information

Trademark by Concert Pharmaceuticals, Inc.

A full line of pharmaceuticals, none of the aforesaid including pharmaceuticals for the treatment of attention deficit hyperactivity disorders and/or attention deficit disorders

Classification Information

Intent to Use Trademark - Applicant has not submitted proof of use in commerce the the USPTO.

Primary Class: Class Details:
Class (005)
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
First Use Anywhere:: Not provided
First Use In Commerce: Not provided
General Information
Word mark: CONCERT PHARMACEUTICALS INC.
Status/Status Date:
NEW APPLICATION FILED
10/31/2022
Serial Number: 97638190
Filing Date: 10/19/2022
Foreign Filing Deadline: Wednesday, April 19, 2023
 
Registration Number: NOT AVAILABLE
Registration Date: NOT AVAILABLE
Goods and Services: A full line of pharmaceuticals, none of the aforesaid including pharmaceuticals for the treatment of attention deficit hyperactivity disorders and/or attention deficit disorders
Mark Description: The mark consists of the word "CONCERT" with the "O" in lower case form and the "N" larger than the other upper case characters with the words "PHARMACEUTICALS INC." appearing in title case below "CONCERT".
Type Of Mark: TradeMark
Published For Opposition Date: N/A
Last Applicant/Owner:
Concert Pharmaceuticals, Inc.
********
********
***** ****
Mark Drawing Code: Drawing with Words in Stylized form
Design Search:
(NO DATA)
Register Type: Principal
Disclaimer: ("PHARMACEUTICALS INC.")
Correspondent:
********
********
***** ****
Current Status:
NEW APPLICATION FILED
10/31/2022
Correspondent Search:
PATRICK J. CONCANNON is a correspondent of CONCERT PHARMACEUTICALS INC. trademark.
Current Overall Rating:
RatingRatingRatingRatingRating

(0 review)

As seen on